American Society of Nephrology

• NCT03649711

  Collaborator, Phase 3, Completed, 76 people, 28 Aug 2018

• Proteinuria after pig kidney xenotransplantation: A potential unifying hypothesis linking mechanical, innate, and adaptive injury pathways

  Kidney X Prize, 1 Sept 2026

Sources: api.crossref.org

• Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

  Board or leadership role, 1 Oct 2026

• Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial

  Consulting or advice, Fees or honoraria, Grants or research support, Board or leadership role, 30 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Innovative holistic treatment for CKM: what lies ahead?

  European journal of internal medicine, 6 Oct 2026

• Executive Summary of the ASN Kidney Health Guidance on the Cardiovascular‐Kidney‐Metabolic Syndrome

  Journal of the American Society of Nephrology : JASN, 3 Sept 2026